Skip to main content
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.35
+0.42 (7.08%)
Jun 2, 2025, 12:37 PM - Market open

Revenue by Product

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
Small Molecule Drugs
67.64M
Log In
Log In
Log In
Log In
Upgrade
Small Molecule Drugs Growth
-14.61%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
United States
67.64M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-14.61%
Log In
Log In
Log In
Log In
Upgrade